Diffusion Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DFFN and buy or sell other stocks, ETFs, and their options commission-free!About DFFN
Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia.
CEORobert J. Cobuzzi
CEORobert J. Cobuzzi
Employees16
Employees16
HeadquartersCharlottesville, Virginia
HeadquartersCharlottesville, Virginia
Founded2001
Founded2001
Employees16
Employees16
DFFN Key Statistics
Market cap758.61M
Market cap758.61M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.12M
Average volume2.12M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.8551
52 Week high$0.8551
52 Week low$0.166
52 Week low$0.166
People also own
Based on the portfolios of people who own DFFN. This list is generated using Robinhood data, and it’s not a recommendation.